Spinal Pump Market
Number of pages: 100 | Report Format: PDF | Published date: May 29, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 302.59 million |
|
Revenue Forecast in 2031 |
US$ 502.6 million |
|
CAGR |
5.8% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global spinal pump market was valued at US$ 302.59 million in 2022 and is expected to register a revenue CAGR of 5.8% to reach US$ 502.6 million by 2031.
Spinal Pump Market Fundamentals
A spinal pump, also known as an intrathecal pump, is a medical device that delivers medication directly to the spinal cord. It is primarily used to manage chronic pain or spasticity (muscle stiffness) caused by conditions such as cancer, multiple sclerosis, or spinal cord injuries. The spinal pump comprises two main components, a small programmable pump, and a catheter. The pump is usually implanted beneath the skin in the abdominal area or the buttocks, while the catheter is threaded into the intrathecal space of the spinal cord. The pump is surgically placed under the skin, typically through a small incision. The catheter is carefully inserted into the intrathecal space in the spine and secured in place. The pump is programmed to deliver a specific amount of medication at predetermined intervals. The medication, often an opioid pain reliever or a muscle relaxant, is stored in the pump's reservoir. The pump delivers the medication through the catheter directly into the cerebrospinal fluid (CSF) surrounding the spinal cord.
Spinal Pump Market Dynamics
Chronic pain conditions, such as cancer-related pain, neuropathic pain, and musculoskeletal disorders, are on the rise globally and are a primary driver for the growth of the global spinal pump market. Spinal pumps offer an effective alternative for managing chronic pain when other ineffective treatments have caused significant side effects. For instance, according to the WHO’s factsheet of July 2022, around 1.71 billion individuals across the globe have musculoskeletal disorders. Technological advancements in spinal pump systems have led to more sophisticated and programmable devices. These advancements allow for precise drug delivery, customizable dosing schedules, and improved patient comfort.
Furthermore, the integration of wireless connectivity and remote monitoring capabilities has further enhanced the convenience and safety of spinal pumps. Spinal pumps were initially used primarily for pain management. However, their applications have expanded to include the treatment of spasticity caused by conditions like multiple sclerosis, cerebral palsy, and spinal cord injuries, this has fueled the growth of the global spinal pump market. Moreover, as awareness about spinal pumps and their benefits grows among healthcare professionals and patients, these devices are more accepted as a treatment modality. The growing body of evidence supporting the efficacy and safety of spinal pumps has also contributed to their wider adoption.
However, spinal pumps and their associated procedures can be expensive. The initial cost of implantation, ongoing maintenance, medication refills, and programming can be a significant financial burden for patients. The high cost of spinal pumps may limit their accessibility, particularly in regions with limited healthcare resources or inadequate insurance coverage. Implanting a spinal pump requires a surgical procedure, which carries inherent risks such as infection, bleeding, or damage to surrounding structures. Additionally, there is a risk of catheter-related complications, such as catheter migration, blockage, or leakage. These risks and potential complications may deter some patients and healthcare professionals from considering or recommending spinal pump therapy. Additionally, high cost, surgical risks & complications, and safety concerns and adverse events are some of the restraints impeding the overall market growth.
Spinal Pump Market Ecosystem
The global spinal pump market is analyzed from four perspectives: type, application, end user, and region.
Spinal Pump Market by Type
Based on the type, the global spinal pump market is segmented into constant-rate pumps and programmable pumps.
The constant-rate pumps segment dominated the market with the principal revenue share in 2022. The constant-rate pumps refer to a specific type of spinal pump that delivers medication constantly over time. These pumps are programmed to provide a continuous medication infusion to manage chronic pain or other conditions requiring a steady and consistent drug delivery. Constant rate pumps are designed to provide a continuous and uninterrupted flow of medication into the intrathecal space of the spinal cord. This allows for consistent pain relief or symptom management throughout the day. Constant rate pumps are typically programmed to deliver medication at a fixed infusion rate, which remains constant over time. The infusion rate is determined based on the patient's individual needs, medication requirements, and the desired therapeutic effect. The programming of constant rate pumps is relatively straightforward. Healthcare professionals set the desired infusion rate based on the patient's condition and adjust it as needed. Once programmed, the pump delivers medication consistently without requiring frequent adjustments. These aspects contribute to the growth of the constant-rate pumps segment.
Spinal Pump Market by Application
Based on the application, the global spinal pump market is segmented into pain management and spasticity management.
The pain management segment accounted for a significant market share, with around 61% of the market share globally. Pain management refers to the use of spinal pumps for the treatment and management of chronic pain conditions. Spinal pumps have emerged as an effective therapeutic option for patients who experience persistent pain that is difficult to manage through conventional methods. Pain management using spinal pumps is primarily focused on chronic pain conditions. These may include cancer-related pain, neuropathic pain, complex regional pain syndrome (CRPS), failed back surgery syndrome (FBSS), and other chronic pain syndromes. Spinal pumps are often considered when other treatments, such as oral medications or invasive procedures, have been ineffective or are associated with significant side effects. These factors contribute to the growth of the pain management segment.
The spasticity management segment dominated the market with the largest revenue share in 2022. The use of spinal pumps for the treatment and management of spasticity. Spasticity is a condition characterized by muscle stiffness, tightness, and involuntary contractions, often resulting from neurological disorders such as multiple sclerosis, cerebral palsy, spinal cord injury, or stroke. Spasticity management medications delivered through spinal pumps often include anti-spasmodic drugs such as baclofen or clonidine. These medications help relax and reduce muscle spasms, improving muscle control, range of motion, and functional abilities. Spinal pumps enable healthcare professionals to customize therapy based on each patient’s needs. The dosage, delivery rate, and programming parameters are tailored to the specific requirements of the patient's spasticity symptoms, allowing for personalized and optimized treatment. These overall factors contribute to the growth of the spasticity management segment.
Spinal Pump Market by End User
Based on the end user, the global spinal pump market is segmented into hospitals & clinics, ambulatory surgery centers, and others.
The hospitals & clinics segment is a key player in the spinal pump market with the largest revenue share in 2022, owing to high footfall. The hospitals & clinics comprise healthcare facilities that provide comprehensive medical services and specialized care for patients requiring spinal pump therapy. These facilities play a crucial role in diagnosing, treating, and managing patients with chronic pain or other conditions that can be addressed through spinal pump therapy. Many hospitals and clinics have specialized pain management centers or departments that focus on diagnosing and treating chronic pain conditions. These centers may have dedicated teams of pain management specialists, including pain physicians, anesthesiologists, neurologists, and nurses, who are experienced in using spinal pumps for pain management. Hospitals and clinics often adopt a multidisciplinary approach to spinal pump therapy. They bring together healthcare professionals from various specialties, such as pain management, neurology, neurosurgery, and pharmacy, to collaborate in evaluating, programming, and monitoring spinal pump therapy. This approach ensures comprehensive and coordinated care for patients receiving spinal pump treatment. These overall factors contribute to the growth of the hospitals & clinics segment.
Spinal Pump Market by Region
Geographically, the global spinal pump market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America dominated the global spinal pump market with the largest revenue share in 2022, with a CAGR of 5.65%, owing to the presence of key market players, musculoskeletal disorders, and chronic pain injury. For instance, according to the Centers for Disease Control and Prevention statistics of April 2023, around 51.6 million adults in the U.S. experienced chronic pain. Additionally, companies across the region are continuously involved in partnerships, mergers, and acquisitions, which are also expected to improve the spinal pump market outlook.
Spinal Pump Market Competitive Landscape
The prominent players operating in the global spinal pump market are:
Spinal Pump Market Strategic Developments
A spinal pump, also known as an intrathecal pump, is a medical device that delivers medication directly to the spinal cord.
The global spinal pump market was valued at US$ 302.59 million in 2022.
The estimated market size of the global spinal pump market in 2031 will be US$ 502.6 million.
The revenue CAGR of the spinal pump market during the forecast period will be 5.8% from 2023 to 2031.
The high cost, surgical risks & complications, and safety concerns and adverse events are factors that are restricting the global market growth to full potential.
*Insights on financial performance are subject to the availability of information in the public domain